Histopathologic subsets of fibrosing alveolitis in patients with systemic sclerosis and their relationship to outcome

被引:549
作者
Bouros, D
Wells, AU
Nicholson, AG
Colby, TV
Polychronopoulos, V
Pantelidis, P
Haslam, PL
Vassilakis, DA
Black, CM
du Bois, RM
机构
[1] Royal Brompton Hosp, London SW3 6LY, England
[2] Royal Free Hosp, London NW3 2QG, England
[3] Mayo Clin, Scottsdale, AZ USA
关键词
fibrosing alveolitis; systemic sclerosis; nonspecific interstitial pneumonia; histopathology; survival;
D O I
10.1164/rccm.2106012
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Fibrosing alveolitis associated with systemic sclerosis (FASSc) has a better prognosis than idiopathic pulmonary fibrosis. In view of recent reports that idiopathic nonspecific interstitial pneumonia (NSIP) has a better prognosis than idiopathic usual interstitial pneumonia (UIP), we classified histologic appearances of surgical lung biopsies performed in 80 patients with FASSc. NSIP (n = 62, 77.5%), subcategorized as cellular NSIP (n = 15) and fibrotic NSIP (n = 47) was much more prevalent than UIP (n = 6), end-stage lung disease (ESL, n = 6), or other patterns (n = 6). There were 25 deaths (NSIP 16/62, 26%; UIP/ESL 6/12, 50%). Five-year survival differed little between NSIP (91%) and UIP/IESL (82%); mortality was associated with lower initial carbon monoxide diffusing capacity (DLCO) and FVC levels (p = 0.004 and p = 0.007, respectively). Survival and serial FVC and DLCO trends did not differ between cellular and fibrotic NSIP. Increased mortality in NSIP was associated with lower initial DLCO levels (p = 0.04), higher BAL eosinophil levels (p = 0.03), and deterioration in DLCO levels during the next 3 years (p < 0.005). We conclude that NSIP is the histopathologic pattern in most patients with FASSc. However, outcome is linked more strongly to disease severity at presentation and serial DLCO trends than to histopathologic findings.
引用
收藏
页码:1581 / 1586
页数:6
相关论文
共 38 条
  • [1] [Anonymous], 1989, Eur Respir J, V2, P561
  • [3] PRELIMINARY CRITERIA FOR THE CLASSIFICATION OF SYSTEMIC-SCLEROSIS (SCLERODERMA)
    不详
    [J]. ARTHRITIS AND RHEUMATISM, 1980, 23 (05): : 581 - 590
  • [4] [Anonymous], 2000, AM J RESP CRIT CARE, V161, P646, DOI DOI 10.1164/AJRCCM.161.2.ATS3-00
  • [5] PULMONARY MANIFESTATIONS OF SCLERODERMA
    ARROLIGA, AC
    PODELL, DN
    MATTHAY, RA
    [J]. JOURNAL OF THORACIC IMAGING, 1992, 7 (02) : 30 - 45
  • [6] Bronchoalveolar lavage for evaluation and management of scleroderma disease of the lung
    Behr, J
    Vogelmeier, C
    Beinert, T
    Meurer, M
    Krombach, F
    Konig, G
    Fruhmann, G
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1996, 154 (02) : 400 - 406
  • [7] Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis
    Bjoraker, JA
    Ryu, JH
    Edwin, MK
    Myers, JL
    Tazelaar, HD
    Schroeder, DR
    Offord, KP
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1998, 157 (01) : 199 - 203
  • [8] Bouros D, 2000, Monaldi Arch Chest Dis, V55, P450
  • [9] BOUROS D, IN PRESS CHEST
  • [10] Nonspecific interstitial pneumonia - Individualization of a clinicopathologic entity in a series of 12 patients
    Cottin, V
    Donsbeck, AV
    Revel, D
    Loire, R
    Cordier, JF
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1998, 158 (04) : 1286 - 1293